Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model
โ Scribed by Y. L. B. Klaver; T. Hendriks; R. M. L. M. Lomme; H. J. T. Rutten; R. P. Bleichrodt; I. H. J. T. de Hingh
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 179 KB
- Volume
- 97
- Category
- Article
- ISSN
- 0007-1323
- DOI
- 10.1002/bjs.7249
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND Hyperthermic intraperitoneal intraoperative chemotherapy (HIIC) combined with cytoreductive surgery (CS) has been proposed as a new multimodal treatment mainly for carcinomatosis of gastrointestinal origin. To evaluate whether this regimen could be used for other tumor ty
## Abstract ## BACKGROUND. Because of scarce data from larger series and nonhomogeneous selection criteria, further information is needed on peritonectomy with hyperthermic intraperitoneal chemotherapy (HIPEC) in managing patients with ovarian peritoneal carcinomatosis. ## METHODS. In an open, p
## Abstract ## Background This study compared the quality of surgery performed under conventional light with near-infrared (NIR) image-guided surgery using a tumour-targeting probe and a portable clinical grade imaging device in a mouse model of peritoneal carcinomatosis. ## Methods Peritoneal c
## Abstract ## BACKGROUND Abdominal sarcomatosis is a rare nosologic entity with a poor prognosis. After a Phase I study on cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy (HIIC), the authors reported the results of the treatment of 60 patients using th